Author:
Lu Chengtao,Jia Yanyan,Song Ying,Li Xueqing,Sun Yuan,Zhao Jinyi,Wang Shan,Shi Lei,Wen Aidong,Ding Li
Funder
National Natural Science Foundation of China
Key Technologies for New Drug Innovation and Development of China
National Administration of Chinese Traditional Medicine of Shannxi
Overall Innovation Project of Shaanxi Province Science and Technology
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference17 articles.
1. The potency of substituted benzimidazoles such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+, K+-ATPase is correlated with the rate of acid-activation of the inhibitor;Morii;Biochem. Pharmacol.,1990
2. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione;Fujisaki;Biochem. Pharmacol.,1991
3. Proton pump inhibitors: pharmacology and rationale for use in gastrointestinal disorders;Richardson;Drugs,1998
4. Annu. Rev. Pharmacol. Toxicol.;Sachs;The pharmacology of the gastric acid pump: the H+, K+ ATPase,1995
5. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori;Tsutsui;Antimicrob. Agents Chemother.,2000
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献